Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis

Exclusion Criteria

• •Participants with any dermatological condition of the face or scalp that could interfere with the clinical evaluations.
• •Hypertrophic AK lesions, open wounds or suspected skin cancers within close proximity of the treatment area.
• •Anticipated need for in-patient hospitalization or in-patient surgery within the next 2 months.
• •Participants unable to comply with the requirements of the study or participants who in the opinion of the study physician should not participate in the study.
• •Participants for whom medical chart is inaccessible to physicians to complete baseline data collection.